Table 2 Second recurrence of pancreatic tumor
From: Pancreatic metastases originating from uterine leiomyosarcoma: a case report
Authors | Primary therapy | Adjuvant therapy | Time to 1st recurrence (months)/site of recurrence | Neoadjuvant treatment | Surgical treatment of 1st recurrence | Adjuvant treatment after 1st recurrence surgery | Time to second recurrence (mo)/site of recurrence | Surgical treatment of second recurrence | Postsurgical adjuvant therapy | Survival after pancreatic surgery |
|---|---|---|---|---|---|---|---|---|---|---|
Iwamoto I et al. [5] | TH + BO (February 2002) | RTh + 18 Gy | 12 Lung | No | Video-assisted thoracic surgery | Chemotherapy Ep + Cy + Ca | Pancreas (12 mo) | DP + Spl | No | Alive, 8 mo |
Alonso GJ et al. [6] | July 2005 | RTh + Br | 5 Lung | Chemotherapy | Upper left lobectomy (7 mo) | Chemotherapy (NA) | Pancreas (8 mo) | Segmental pancreatectomy | Recurrence in the lung and liver; bevacizumab (18 mo) | Alive, 18 mo |
Hernandez S et al. [14] | H + BO (November 2003 | RTh | Lung (2 mo, February 2004) | Ifosfamide + A + Mesna | Segmentary resection | Gemcitabine | Pancreas (47 mo, January 2008 | PD (April 2008) | NA | Alive, 67 mo |
Clemente G et al. [13] | H + BO | NA | 144 | NA | PD | NA | NA | NA | NA | NA |
Chatzipantelis P et al. [17] | NA | NA | Left axillary and right femoral metastases | NA | NA | Pancreas (FNA) positive for malignancy (120 mo) | DP + Spl |